Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 12869555
Martinez LO, et al. (2003) Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 278, 37368-74 12869555
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T1286-p - ABCA1 (mouse)
Modsite: QSCLHPFtEDDAVDP SwissProt Entrez-Gene
Orthologous residues
ABCA1 (human): T1286‑p, ABCA1 iso100 (human): T1286‑p, ABCA1 (mouse): T1286‑p, ABCA1 (rat): T1226‑p
Characterization
Methods used to characterize site in vivo [32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site, western blotting
Relevant cell lines - cell types - tissues:  293 (epithelial), macrophage-peritoneum
Cellular systems studied:  cell lines, primary cells
Species studied:  human, mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
apoA-I decrease
apigenin no change compared to control
H-89 decrease
Downstream Regulation
Effect of modification (function):  protein degradation, protein processing
Comments:  Mutants showed increase of cell surface protein levels., T1286A and T1305A mutants are not degraded by calpain or stabilized by apoA-1.

T1305-p - ABCA1 (mouse)
Modsite: IDPESREtDLLSGMD SwissProt Entrez-Gene
Orthologous residues
ABCA1 (human): T1305‑p, ABCA1 iso100 (human): T1305‑p, ABCA1 (mouse): T1305‑p, ABCA1 (rat): T1245‑p
Characterization
Methods used to characterize site in vivo [32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site, western blotting
Relevant cell lines - cell types - tissues:  293 (epithelial), macrophage-peritoneum
Cellular systems studied:  cell lines, primary cells
Species studied:  human, mouse
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
apoA-I decrease
apigenin no change compared to control
H-89 decrease
Downstream Regulation
Effect of modification (function):  protein degradation, protein processing
Comments:  Mutants showed increase of cell surface protein levels., T1286A and T1305A mutants are not degraded by calpain or stabilized by apoA-1.